Showing 1 - 4 of 4
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of trastuzumab, Roche Pharmaceuticals, to submit evidence for the clinical and cost effectiveness of this drug for the treatment of advanced gastric cancer (aGC), as part of the Institute’s single...
Persistent link: https://www.econbiz.de/10010848963
Persistent link: https://www.econbiz.de/10005925512
Persistent link: https://www.econbiz.de/10001100700
Persistent link: https://www.econbiz.de/10001252058